RE26 Oral Chemotherapy Adherence Research Grant - $100,000

RE26 Oral Chemotherapy Adherence Research Grant - $100,000

Status: ACTIVE
Funder: Oncology Nursing Society
Amount: US $100,000
Last Updated: April 02, 2026

Summary

The RE26 Oral Chemotherapy Adherence Research Grant, funded by the Oncology Nursing Society, offers $100,000 to established oncology nurse researchers. This grant aims to support rigorous research focused on improving adherence to oral chemotherapy treatments. Eligible applicants must be doctorally prepared registered oncology nurses with prior research funding of at least $50,000. Research topics include patient-centric symptom science and effective cancer care delivery models.

Overview

RE26 Oral Chemotherapy Adherence Research Grant - $100,000 This opportunity is intended for established oncology nurse researchers with a demonstrated funding history of at least $50,000 in prior research funding. Purpose To support rigorous scientific oncology nursing research through a major-focused grant. Research projects must address oral chemotherapy adherence. Research Priority Topics Advance patient-centric, precision symptom scienceProvide evidence for safe and effective cancer care delivery models and support of the cancer-nursing workforceDescribe the impact of the environment on cancer care outcomesIntegrate patient navigation into cancer care across the trajectoryAdvance the use of innovative methodologies in oncology nursing research

Eligibility

You can learn more about this opportunity by visiting the funder's website. The PI (individual primarily responsible for implementing the proposal and reporting to the Oncology Nursing Foundation) must be a registered oncology nurse actively involved in some aspect of cancer patient care, education, or research. The PI must be doctorally-prepared (only one PI can appear on the grant). The PI must have received and completed at least one research study with a funding level of at least $50,000 as the study PI.